Janus Henderson Group PLC Repligen Corp Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Repligen Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,499 shares of RGEN stock, worth $376,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,499

Previous 3,968 37.02%

Holding current value

$376,024

Previous $729,000 56.79%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $176,280 - $268,753	-1,469 Reduced 37.02%	2,499 $315,000
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $9.11 Million - $11.1 Million	-53,315 Reduced 93.07%	3,968 $729,000
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $970,673 - $1.58 Million	8,502 Added 17.43%	57,283 $10.3 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $1.47 Million - $1.87 Million	10,607 Added 27.79%	48,781 $7.76 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $37,788 - $49,224	-273 Reduced 0.71%	38,174 $5.4 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $5.37 Million - $6.9 Million	34,834 Added 964.13%	38,447 $6.47 Million
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $3.39 Million - $4.61 Million	-20,896 Reduced 85.26%	3,613 $611,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $2.29 Million - $3.66 Million	14,282 Added 139.65%	24,509 $4.59 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $7,878 - $10,529	-56 Reduced 0.54%	10,227 $1.66 Million
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $6,608 - $10,576	-41 Reduced 0.4%	10,283 $1.93 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $1.25 Million - $1.54 Million	5,060 Added 96.12%	10,324 $2.74 Million
Q3 2021 Nov 16, 2021	BUY	$194.77 - $324.21 $1.03 Million - $1.71 Million	5,264 New	5,264 $1.52 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $5.31 Million - $7.08 Million	-32,025 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $1.66 Million - $2.08 Million	9,186 Added 40.22%	32,025 $6.23 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $15,252 - $21,276	-103 Reduced 0.45%	22,839 $4.38 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $2.81 Million - $3.63 Million	22,942 New	22,942 $3.39 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

53.8M

Call Options Held

423K

Put Options Held

85.3K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.35B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Repligen Corp Transaction History